Crown Advisors Management’s Tandem Diabetes Care TNDM Stock Holding History

Crown Advisors Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,000	Closed	-$3.76M	–	49
2021 Q4	$3.76M	Hold	25,000	–	–	2.42%	19
2021 Q3	$2.98M	Hold	25,000	–	–	2.1%	21
2021 Q2	$2.44M	Hold	25,000	–	–	1.68%	27
2021 Q1	$2.21M	Sell	25,000 -15,000	-38%	-$1.39M	1.73%	28
2020 Q4	$3.83M	Hold	40,000	–	–	2.74%	17
2020 Q3	$4.54M	Sell	40,000 -10,000	-20%	-$1.05M	2.95%	13
2020 Q2	$4.95M	Hold	50,000	–	–	3.39%	8
2020 Q1	$3.22M	Hold	50,000	–	–	2.54%	20
2019 Q4	$2.98M	Sell	50,000 -25,000	-33%	-$1.54M	1.92%	27
2019 Q3	$4.42M	Sell	75,000 -25,000	-25%	-$1.6M	2.96%	10
2019 Q2	$6.45M	Hold	100,000	–	–	4.47%	2
2019 Q1	$6.35M	Buy	100,000 +25,000	+33%	+$1.31M	4.77%	2
2018 Q4	$2.85M	Buy	+75,000	New	+$2.65M	2.96%	13

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Crown Advisors Management's TNDM Position: Q1 2022 in Review

Crown Advisors Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 25,000 shares — an estimated $3.76M sold.

Crown Advisors Management first reported a position in TNDM in Q4 2018 and held it in 13 quarters. The position peaked at $6.45M in Q2 2019. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

Crown Advisors Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
Crown Advisors Management sold 25,000 Tandem Diabetes Care shares in Q1 2022, an estimated $3.76M.
Crown Advisors Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 13 quarters.
Crown Advisors Management's Tandem Diabetes Care position peaked at $6.45M in Q2 2019.
379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Crown Advisors Management's 13F filing for Q1 2022, filed 12 May 2022.